International Paper
IP
31.82
-0.32
-1.00%
International Paper
US · IP
#1010 by market cap
Listed 1970
31.82
-0.32
-1.00%
Live - 5344 symbols - heartbeat 25s ago
· 2026-10-08 06:33
Pre-market
31.42
-1.26%
After-hours
31.35
-1.48%
Overnight
31.82
0.00%
- Market cap
- 16.85B
- P/E (TTM)i
- -4.68
- P/Bi
- 1.17
- EPSi
- -6.95
- Div yieldi
- 5.81%
- 52W posi
- 17%
Reader sentiment
Are you bullish or bearish on IP?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.31, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +49.25% YoY
Margins
- Gross margin
- 29.61%
- Operating margin
- -0.04%
- Net margin
- -14.88%
Key ratios & quality
- Enterprise valuei
- 25.54B
- Altman Z-Scorei
- 1.31
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 23.31B | 18.32B | 17.57B | 19.36B | 21.16B | 16.03B | 15.84B | 23.63B |
| Gross profit | 7.75B | 5.65B | 5.23B | 5.53B | 6.02B | 4.52B | 4.44B | 7.00B |
| Selling & admin expenses | 3.29B | 2.70B | 2.64B | 2.83B | 3.08B | 2.50B | 2.88B | 4.05B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 2.96B | 1.74B | 1.36B | 1.47B | 1.75B | 751.00M | 585.00M | -10.00M |
| Pretax profit | 1.78B | 921.00M | 329.00M | 999.00M | 1.51B | 402.00M | 369.00M | -3.37B |
| Tax | 445.00M | 477.00M | 176.00M | 188.00M | -236.00M | 68.00M | -361.00M | -533.00M |
| Net profit | 2.02B | 1.22B | 482.00M | 1.75B | 1.50B | 288.00M | 557.00M | -3.52B |
| Basic EPS | 5 | 3 | 1 | 5 | 4 | 1 | 2 | -7 |
| Diluted EPS | 4.85 | 3.07 | 1.22 | 4.47 | 4.10 | 0.82 | 1.57 | -6.95 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 5.26B | 6.14B | 6.22B | 6.01B | 5.97B | 6.00B |
| Gross profit | 1.46B | 1.72B | 1.94B | 1.88B | 1.73B | 1.66B |
| Selling & admin expenses | 904.00M | 1.04B | 1.02B | 1.09B | 1.02B | 1.09B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -52.00M | 207.00M | -221.00M | 56.00M | 174.00M | 43.00M |
| Pretax profit | -155.00M | 116.00M | -675.00M | -2.65B | 93.00M | -26.00M |
| Tax | -32.00M | 40.00M | -250.00M | -291.00M | 17.00M | -15.00M |
| Net profit | -105.00M | 75.00M | -1.10B | -2.38B | 60.00M | -12.00M |
| Basic EPS | 0 | 0 | -2 | -5 | 0 | 0 |
| Diluted EPS | -0.24 | 0.14 | -2.09 | -4.52 | 0.11 | -0.02 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 7.00B | 6.64B | 11.24B | 7.10B | 6.77B | 6.61B | 6.42B | 10.11B |
| Cash & ST investments | 589.00M | 511.00M | 5.32B | 1.54B | 804.00M | 1.11B | 1.06B | 1.15B |
| Inventory | 2.24B | 2.21B | 1.63B | 1.81B | 1.94B | 1.89B | 1.49B | 2.01B |
| Total assets | 33.58B | 33.47B | 31.72B | 25.24B | 23.94B | 23.26B | 22.80B | 37.96B |
| Total current liabilities | 4.69B | 8.65B | 8.28B | 4.14B | 5.00B | 3.96B | 4.26B | 7.90B |
| Short-term debt | 639.00M | 4.39B | 4.25B | 196.00M | 763.00M | 138.00M | 191.00M | 992.00M |
| Long-term debt | 16.31B | 11.68B | 8.04B | 5.38B | 4.82B | 5.46B | 5.36B | 8.84B |
| Total liabilities | 26,193,000,000.00 | 25,753,000,000.00 | 23,850,000,000.00 | 16,161,000,000.00 | 15,443,000,000.00 | 14,906,000,000.00 | 14,627,000,000.00 | 23,137,000,000.00 |
| Total equity | 7.38B | 7.72B | 7.87B | 9.08B | 8.50B | 8.36B | 8.17B | 14.83B |
| Retained earnings | 7.47B | 8.41B | 8.07B | 9.03B | 9.86B | 9.49B | 9.39B | 4.89B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 9.29B | 9.50B | 10.46B | 10.11B | 8.58B | 8.24B |
| Cash & ST investments | 1.16B | 1.14B | 995.00M | 1.15B | 1.24B | 726.00M |
| Inventory | 2.59B | 2.66B | 2.18B | 2.01B | 1.90B | 1.96B |
| Total assets | 41.17B | 42.38B | 40.57B | 37.96B | 36.43B | 36.52B |
| Total current liabilities | 6.99B | 7.12B | 7.97B | 7.90B | 7.07B | 7.51B |
| Short-term debt | 444.00M | 225.00M | 972.00M | 992.00M | 918.00M | 1.00B |
| Long-term debt | 9.18B | 9.69B | 8.99B | 8.84B | 8.18B | 8.22B |
| Total liabilities | 23,076,000,000.00 | 23,759,000,000.00 | 23,251,000,000.00 | 23,137,000,000.00 | 21,626,000,000.00 | 22,066,000,000.00 |
| Total equity | 18.09B | 18.62B | 17.32B | 14.83B | 14.81B | 14.46B |
| Retained earnings | 9.04B | 8.87B | 7.52B | 4.89B | 4.70B | 4.44B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 3.23B | 3.61B | 3.06B | 2.03B | 2.17B | 1.83B | 1.68B | 1.70B |
| Depreciation & amortization | 1.33B | 1.31B | 1.29B | 1.21B | 1.04B | 1.43B | 1.31B | 2.88B |
| Free cash flow | 1.65B | 2.33B | 2.31B | 1.48B | 1.24B | 692.00M | 757.00M | -159.00M |
| Dividends paid | -789.00M | -796.00M | -806.00M | -780.00M | -673.00M | -642.00M | -643.00M | -977.00M |
| Stock buybacks / issuance | -732.00M | -535.00M | -42.00M | -839.00M | -1.28B | -218.00M | -23.00M | -65.00M |
| Ending cash balance | 589.00M | 511.00M | 595.00M | 1.30B | 804.00M | 1.11B | 1.17B | 1.16B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -288.00M | 476.00M | 605.00M | 905.00M | 611.00M | 526.00M |
| Depreciation & amortization | 571.00M | 480.00M | 1.13B | 698.00M | 489.00M | 488.00M |
| Free cash flow | -618.00M | 54.00M | 150.00M | 255.00M | 94.00M | -7.00M |
| Dividends paid | -244.00M | -244.00M | -245.00M | -244.00M | -245.00M | -245.00M |
| Stock buybacks / issuance | -62.00M | -1.00M | -1.00M | -1.00M | -30.00M | -1.00M |
| Ending cash balance | 1.16B | 1.14B | 1.01B | 1.16B | 1.31B | 726.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 28.98 | 16.25 | 6.19 | 20.69 | 17.11 | 3.42 | 6.74 | -30.57 |
| ROA %i | 5.96 | 3.65 | 1.48 | 6.15 | 6.12 | 1.22 | 2.42 | -11.57 |
| ROIC %i | 10.00 | 6.28 | 3.25 | 10.81 | 11.93 | 3.38 | 5.03 | -16.36 |
| 5-year avg ROE %i | 23.94 | 25.51 | 22.58 | 22.32 | 17.85 | 12.73 | 10.83 | 3.48 |
| EBIT margin %i | 10.79 | 10.32 | 6.07 | 7.38 | 9.04 | 4.25 | 3.10 | -11.92 |
| FCF / sales %i | 7.10 | 10.43 | 11.23 | 7.65 | 5.87 | 3.66 | 4.07 | -- |
| Current ratioi | 1.49 | 0.77 | 1.36 | 1.71 | 1.35 | 1.67 | 1.51 | 1.28 |
| Quick ratioi | 0.96 | 0.48 | 1.00 | 1.24 | 0.91 | 1.16 | 0.90 | 0.71 |
| Debt / assetsi | 50.49 | 48.92 | 39.55 | 23.04 | 24.49 | 25.39 | 25.54 | 27.18 |
| LT debt / equityi | 221.58 | 155.40 | 105.65 | 61.87 | 60.01 | 69.02 | 68.90 | 62.89 |
| Interest coveragei | 3.43 | 3.27 | 2.08 | 3.32 | 4.75 | 1.91 | 1.34 | -5.11 |
| Revenue CAGR (3Y) %i | 4.07 | -2.06 | -6.87 | -5.99 | 4.93 | -3.00 | -6.48 | 3.75 |
| Net income CAGR (3Y) %i | 28.97 | 10.66 | -39.19 | -4.51 | 7.08 | -15.77 | -31.75 | -- |
| FCF CAGR (3Y) %i | 14.81 | 27.35 | 84.86 | -3.62 | -18.94 | -33.11 | -20.04 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 3.01 | -0.20 | -9.86 | -30.57 | -20.37 | -20.79 |
| ROA %i | 1.23 | -0.08 | -4.01 | -11.57 | -8.64 | -8.72 |
| ROIC %i | 2.72 | 0.89 | -4.31 | -16.36 | -11.59 | -11.86 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 1.91 | 1.49 | -1.12 | -11.92 | -10.57 | -11.26 |
| FCF / sales %i | -- | -- | -- | -- | 2.27 | 2.03 |
| Current ratioi | 1.33 | 1.33 | 1.31 | 1.28 | 1.21 | 1.10 |
| Quick ratioi | 0.88 | 0.89 | 0.72 | 0.71 | 0.84 | 0.75 |
| Debt / assetsi | 24.52 | 24.53 | 25.67 | 27.18 | 26.19 | 26.53 |
| LT debt / equityi | 53.35 | 54.62 | 54.51 | 62.89 | 58.25 | 60.09 |
| Interest coveragei | 0.84 | 0.67 | -0.49 | -5.11 | -4.69 | -5.09 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Packaging Solutions North America (PS NA) is the largest reported line at 61.43% of revenue, across 4 reported segments.
- Packaging Solutions Europe, Middle East and Africa (PS EMEA) follows at 38.09%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Packaging Solutions North America (PS NA)61.43%
Packaging Solutions Europe, Middle East and Africa (PS EMEA)38.09%
Other external sales0.80%
Quote time 2026-10-08 06:33:12 · For reference only, not investment advice and not tailored to your situation.